BTI Stock Recent News

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.74%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 9%.

I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-volatility aristocrats offer a 3.4% yield, a 46% downside capture ratio, and 52% less volatility than the S&P, making them ideal for addressing recession concerns while still providing a 23% return. High-yield aristocrats offer a 7% average yield with 11%-12% long-term return potential, providing low-risk income regardless of market or economic conditions.

The stock market has switched gears in 2025. Growth stocks that were crushing it in 2023 and 2024 have gone south, while steady value stocks with dividend payments have outperformed the broad market indices.

The big draw with British American Tobacco (BTI -0.51%) today is its huge 7% dividend yield. That's nearly three times the consumer staples average yield of 2.5%.

Alphabet's strong earnings and $75 billion capex reaffirmation set a bullish tone for big tech, boosting market confidence and economic outlook. The Dividend Harvesting Portfolio rose 2.46%, reaching a balance of $26,353.05, with a 21.44% return on invested capital and $2,179.74 in forward dividend income. Added to positions in Starwood Property Trust, Pfizer, and started a new position in Schlumberger, focusing on undervalued stocks with strong long-term potential.

Are you looking for more income from your portfolio? Even with bond yields still near multiyear highs, plenty of dividend stocks are worth considering.

British American Tobacco is poised for accelerating NGP growth with innovations like Velo Plus, Glo Hilo, and Vuse Ultra. Velo Plus, a synthetic nicotine pouch, is gaining traction in the US market, potentially driving significant growth in the modern oral segment. Glo Hilo and Vuse Ultra are set for global launches, promising accelerated growth in the years ahead.

Tobacco stocks aren't for everyone. The fact that they deal in vices and sell addictive products is off-putting to some, while others skip over them in favor of faster-growing businesses.

Philip Morris's stock surged over 41.50% in 2025, driven by the success of its innovative nicotine pouch product, Zyn, which received FDA marketing approval. British American Tobacco's VELO Plus, a Zyn competitor, offers synthetic nicotine, improved pouches, and competitive pricing, capturing 5.4% market share within 12 weeks of launch. BAT trades at a lower valuation compared to Philip Morris and Altria, with a P/E ratio of 9.34x and a 7.05% dividend yield, making it an attractive buy.

The US nicotine market is rapidly shifting to non-combustible products, with Philip Morris leading through Zyn and British American Tobacco focusing on Velo and Vuse. BTI's US business is crucial, making up half of their global operating profits, while they face challenges from illicit vape products and a sputtering start in nicotine pouches. BAT's strong cash generation and dividend yield of 7% highlight its financial health, despite near-term revenue growth challenges and regulatory risks.